<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05618509</url>
  </required_header>
  <id_info>
    <org_study_id>2021-A01932-39</org_study_id>
    <nct_id>NCT05618509</nct_id>
  </id_info>
  <brief_title>Immediate Effects of STENDO on the Walking Abilities of Patients With COPD (STENDO-COPD)</brief_title>
  <acronym>STENDO-COPD</acronym>
  <official_title>Immediate Effects of STENDO on the Walking Abilities of Patients With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elsan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Elsan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The STENDO process is a heart rate synchronized massage system initially validated for the&#xD;
      treatment of lymphedema. It is a combination enveloping the lower limbs up to the abdomen.&#xD;
      The massage system induces pressure from the ankles to the abdomen between each heartbeat.&#xD;
      This technique would also allow an improvement of endothelial function by a greater release&#xD;
      of nitric oxide. Thus the capacity for physical exercise is potentially improved.&#xD;
&#xD;
      The use of STENDO has never been evaluated in COPD (Chronic obstructive pulmonary disease)&#xD;
      where physical capacity is impaired with, in particular, the presence of endothelial&#xD;
      dysfunction. STENDO may improve walking performance. If these hypotheses are validated, the&#xD;
      STENDO could be positioned as a complement to the exercise rehabilitation strategies offered&#xD;
      to symptomatic COPD patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2023</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation in the 6-minute walk test distance after the performance of the STENDO/STENDO Placebo session compared to the value of the initial 6-minute walk test..</measure>
    <time_frame>Baseline to immediately after STENDO/STENDO Placebo procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>COPD</condition>
  <condition>Walking Performance</condition>
  <arm_group>
    <arm_group_label>Patient with STENDO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient with placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STENDO session</intervention_name>
    <description>It is a combination enveloping the lower limbs up to the abdomen. The massage system induces pressure from the ankles to the abdomen between each heartbeat. The capacity for physical exercise is potentially improved.&#xD;
STENDO : 45 minutes, 2 legs and the pelvis, pression of 65mm Hg</description>
    <arm_group_label>Patient with STENDO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>A six-minute walking distance test</intervention_name>
    <description>Before and after STENDO session, the patient has to walk 6 minutes in a flat corridor (30m long)</description>
    <arm_group_label>Patient with STENDO</arm_group_label>
    <arm_group_label>Patient with placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Near Infrared Spectroscopy</intervention_name>
    <description>The goal is to measure the evolution of the oxygen consumption of the right leg during an effort on a bicycle at constant power for 5 minutes.</description>
    <arm_group_label>Patient with STENDO</arm_group_label>
    <arm_group_label>Patient with placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>STENDO placebo</intervention_name>
    <description>STENDO placebo : 45 minutes, on 2 legs and the pelvis, pression of 10 mmHg</description>
    <arm_group_label>Patient with placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic chronic obstructive pulmonary disease (COPD) attested by a Tiffeneau ratio&#xD;
             &lt;70%&#xD;
&#xD;
          -  Not oxygen dependent&#xD;
&#xD;
          -  Oriented for an ambulatory effort rehabilitation program in after-care and&#xD;
             rehabilitation&#xD;
&#xD;
          -  Negative urine pregnancy test in women of childbearing age&#xD;
&#xD;
          -  Affiliation to a social security scheme or beneficiary of such a scheme&#xD;
&#xD;
          -  Patient having signed the free and informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neurological or osteo-articular pathology impeding walking.&#xD;
&#xD;
          -  Dementia with MMSE (Mini mental state examination) &lt;24/30&#xD;
&#xD;
          -  Heart failure&#xD;
&#xD;
          -  Covid + in the previous 3 months&#xD;
&#xD;
          -  Major surgery in the year preceding the session&#xD;
&#xD;
          -  Heavy abdominal, pelvic and lower limb cosmetic surgery in the year preceding the&#xD;
             session&#xD;
&#xD;
          -  Impaired comprehension and/or expression&#xD;
&#xD;
          -  Being simultaneously on oral contraception (pill) and smoking (more than 10 cigarettes&#xD;
             per day)&#xD;
&#xD;
          -  Severe unbalanced high blood pressure&#xD;
&#xD;
          -  severe peripheral neuropathy&#xD;
&#xD;
          -  Colostomy&#xD;
&#xD;
          -  Open fracture, bleeding or healing wound&#xD;
&#xD;
          -  3rd degree burn&#xD;
&#xD;
          -  Liver cirrhosis&#xD;
&#xD;
          -  Bedsore&#xD;
&#xD;
          -  Have prohibitions and restrictions with a history of phlebitis or recent progressive&#xD;
             venous thrombosis (less than 6 months) or arterial disease of the lower limbs stage 3&#xD;
             and 4&#xD;
&#xD;
          -  Refusal to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jeanfrancois.oudet@free.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Polyclinique de l'Ormeau</name>
      <address>
        <city>Tarbes</city>
        <zip>65000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mars Labrunee, Dr</last_name>
      <phone>06 10 97 68 70</phone>
      <email>drlabrunee@polyclinique-Ormeau.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>November 8, 2022</study_first_submitted>
  <study_first_submitted_qc>November 15, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>February 20, 2023</last_update_submitted>
  <last_update_submitted_qc>February 20, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

